Role of interleukins in heart failure with reduced ejection fraction
Heart failure (HF) is the leading cause of morbidity and mortality in developed countries, and it is the primary cause of mortality in the elderly worldwide. The processes of inflammatory response activation, production and release of pro-inflammatory cytokines, activation of the complement system,...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2019-11-01
|
| Series: | Anatolian Journal of Cardiology |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-32748 |
| _version_ | 1797907039339413504 |
|---|---|
| author | Oliwia Anna Segiet Adam Piecuch Lukasz Mielanczyk Marek Michalski Ewa Nowalany-kozielska |
| author_facet | Oliwia Anna Segiet Adam Piecuch Lukasz Mielanczyk Marek Michalski Ewa Nowalany-kozielska |
| author_sort | Oliwia Anna Segiet |
| collection | DOAJ |
| description | Heart failure (HF) is the leading cause of morbidity and mortality in developed countries, and it is the primary cause of mortality in the elderly worldwide. The processes of inflammatory response activation, production and release of pro-inflammatory cytokines, activation of the complement system, synthesis of autoantibodies, and overexpression of Class II major histocompatibility complex molecules contribute to the HF development and progression. High levels of circulating cytokines correlate with the severity of HF, measured with the use of New York Heart Association's classification, and prognosis of the disease. In HF, there is an imbalance between pro-inflammatory and anti-inflammatory cytokines. Concentrations of several interleukins are increased in HF, including IL-1β, IL-6, IL-8, IL-9, IL-10, IL-13, IL-17, and IL-18, whereas the levels of IL-5, IL-7, or IL-33 are down-regulated. Concentrations of inflammatory mediators are associated with cardiac function and can be HF markers and predictors of adverse outcomes or mortality. This review presents the role of interleukins, which contribute to the HF initiation and progression, the importance of their pathways in transition from myocardial injury to HF, and the role of interleukins as markers of disease severity and outcome predictors. |
| first_indexed | 2024-04-10T10:31:20Z |
| format | Article |
| id | doaj.art-c4dc4ee1851a44a5b973337f4bb251d6 |
| institution | Directory Open Access Journal |
| issn | 2149-2263 |
| language | English |
| last_indexed | 2024-04-10T10:31:20Z |
| publishDate | 2019-11-01 |
| publisher | KARE Publishing |
| record_format | Article |
| series | Anatolian Journal of Cardiology |
| spelling | doaj.art-c4dc4ee1851a44a5b973337f4bb251d62023-02-15T16:21:08ZengKARE PublishingAnatolian Journal of Cardiology2149-22632019-11-0122628729910.14744/AnatolJCardiol.2019.32748AJC-32748Role of interleukins in heart failure with reduced ejection fractionOliwia Anna Segiet0Adam Piecuch1Lukasz Mielanczyk2Marek Michalski3Ewa Nowalany-kozielska42nd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice; Zabrze-Poland2nd Department of Histology and Cell PathologySchool of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice; Zabrze-Poland2nd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice; Zabrze-Poland2nd Department of Histology and Cell PathologySchool of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice; Zabrze-Poland2nd Department of Histology and Cell PathologySchool of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice; Zabrze-PolandHeart failure (HF) is the leading cause of morbidity and mortality in developed countries, and it is the primary cause of mortality in the elderly worldwide. The processes of inflammatory response activation, production and release of pro-inflammatory cytokines, activation of the complement system, synthesis of autoantibodies, and overexpression of Class II major histocompatibility complex molecules contribute to the HF development and progression. High levels of circulating cytokines correlate with the severity of HF, measured with the use of New York Heart Association's classification, and prognosis of the disease. In HF, there is an imbalance between pro-inflammatory and anti-inflammatory cytokines. Concentrations of several interleukins are increased in HF, including IL-1β, IL-6, IL-8, IL-9, IL-10, IL-13, IL-17, and IL-18, whereas the levels of IL-5, IL-7, or IL-33 are down-regulated. Concentrations of inflammatory mediators are associated with cardiac function and can be HF markers and predictors of adverse outcomes or mortality. This review presents the role of interleukins, which contribute to the HF initiation and progression, the importance of their pathways in transition from myocardial injury to HF, and the role of interleukins as markers of disease severity and outcome predictors.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-32748interleukinsheart failureinterleukin-1interleukin-6interleukin-33. |
| spellingShingle | Oliwia Anna Segiet Adam Piecuch Lukasz Mielanczyk Marek Michalski Ewa Nowalany-kozielska Role of interleukins in heart failure with reduced ejection fraction Anatolian Journal of Cardiology interleukins heart failure interleukin-1 interleukin-6 interleukin-33. |
| title | Role of interleukins in heart failure with reduced ejection fraction |
| title_full | Role of interleukins in heart failure with reduced ejection fraction |
| title_fullStr | Role of interleukins in heart failure with reduced ejection fraction |
| title_full_unstemmed | Role of interleukins in heart failure with reduced ejection fraction |
| title_short | Role of interleukins in heart failure with reduced ejection fraction |
| title_sort | role of interleukins in heart failure with reduced ejection fraction |
| topic | interleukins heart failure interleukin-1 interleukin-6 interleukin-33. |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-32748 |
| work_keys_str_mv | AT oliwiaannasegiet roleofinterleukinsinheartfailurewithreducedejectionfraction AT adampiecuch roleofinterleukinsinheartfailurewithreducedejectionfraction AT lukaszmielanczyk roleofinterleukinsinheartfailurewithreducedejectionfraction AT marekmichalski roleofinterleukinsinheartfailurewithreducedejectionfraction AT ewanowalanykozielska roleofinterleukinsinheartfailurewithreducedejectionfraction |